Connection

David Neskey to Humans

Back to Details
This is a "connection" page, showing publications David Neskey has written about Humans.
David Neskey
Connection Strength
0.488
Humans
  1. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol. 2022 11; 134:106127.
    View in: PubMed
    Score: 0.032
  2. Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
    View in: PubMed
    Score: 0.031
  3. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.030
  4. Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy. Trends Cancer. 2019 04; 5(4):208-232.
    View in: PubMed
    Score: 0.025
  5. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
    View in: PubMed
    Score: 0.025
  6. Impact of Delay in Treatment Initiation on Overall Survival in Laryngeal Cancers. Otolaryngol Head Neck Surg. 2019 04; 160(4):651-657.
    View in: PubMed
    Score: 0.024
  7. Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
    View in: PubMed
    Score: 0.022
  8. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer. Oncotarget. 2017 Apr 04; 8(14):22991-23007.
    View in: PubMed
    Score: 0.022
  9. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Res. 2015 Apr 01; 75(7):1527-36.
    View in: PubMed
    Score: 0.019
  10. Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1195-202.
    View in: PubMed
    Score: 0.017
  11. Nasal, septal, and turbinate anatomy and embryology. Otolaryngol Clin North Am. 2009 Apr; 42(2):193-205, vii.
    View in: PubMed
    Score: 0.013
  12. Endostatin and anastellin inhibit distinct aspects of the angiogenic process. J Exp Clin Cancer Res. 2008 Nov 04; 27:61.
    View in: PubMed
    Score: 0.012
  13. Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer. Cancer Res. 2022 12 02; 82(23):4386-4399.
    View in: PubMed
    Score: 0.008
  14. B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity. J Immunother Cancer. 2022 01; 10(1).
    View in: PubMed
    Score: 0.008
  15. Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis. Target Oncol. 2021 11; 16(6):743-752.
    View in: PubMed
    Score: 0.008
  16. Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100411.
    View in: PubMed
    Score: 0.008
  17. Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies. Oncoimmunology. 2021; 10(1):1959101.
    View in: PubMed
    Score: 0.007
  18. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.007
  19. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.007
  20. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.007
  21. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.007
  22. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma. Cancer. 2020 10 15; 126(20):4498-4510.
    View in: PubMed
    Score: 0.007
  23. Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells. Eur J Immunol. 2020 09; 50(9):1386-1399.
    View in: PubMed
    Score: 0.007
  24. Incidence and survival trends of parotid malignancies over 42?years. Head Neck. 2020 09; 42(9):2308-2315.
    View in: PubMed
    Score: 0.007
  25. Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma. BMC Cancer. 2020 Mar 17; 20(1):229.
    View in: PubMed
    Score: 0.007
  26. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.007
  27. Carcinoma ex pleomorphic adenoma: A review of incidence, demographics, risk factors, and survival. Am J Otolaryngol. 2019 Nov - Dec; 40(6):102279.
    View in: PubMed
    Score: 0.006
  28. Salivary Carcinosarcoma: An Extremely Rare and Highly Aggressive Malignancy. Laryngoscope. 2020 05; 130(5):E335-E339.
    View in: PubMed
    Score: 0.006
  29. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
    View in: PubMed
    Score: 0.006
  30. Metastatic Salivary Ductal Carcinoma to the Mastoid Segment of the Facial Nerve. Otol Neurotol. 2018 09; 39(8):e722-e725.
    View in: PubMed
    Score: 0.006
  31. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019 02; 160(2):284-294.
    View in: PubMed
    Score: 0.006
  32. Is imaging of the brain necessary at diagnosis for cutaneous head and neck melanomas? Am J Otolaryngol. 2018 Sep - Oct; 39(5):631-635.
    View in: PubMed
    Score: 0.006
  33. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
    View in: PubMed
    Score: 0.006
  34. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.006
  35. Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck. Laryngoscope. 2018 04; 128(4):885-888.
    View in: PubMed
    Score: 0.006
  36. Ewing Sarcoma of the Head and Neck. Ann Otol Rhinol Laryngol. 2017 Mar; 126(3):179-184.
    View in: PubMed
    Score: 0.005
  37. RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC. PLoS Genet. 2016 09; 12(9):e1006306.
    View in: PubMed
    Score: 0.005
  38. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Res. 2015 Apr 01; 75(7):1205-15.
    View in: PubMed
    Score: 0.005
  39. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence. Mol Cancer Ther. 2015 Feb; 14(2):608-19.
    View in: PubMed
    Score: 0.005
  40. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014 Jul 15; 20(14):3842-8.
    View in: PubMed
    Score: 0.005
  41. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Mol Cancer Ther. 2013 Sep; 12(9):1860-73.
    View in: PubMed
    Score: 0.004
  42. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med. 2014 Jan; 43(1):28-34.
    View in: PubMed
    Score: 0.004
  43. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013 Jul; 3(7):770-81.
    View in: PubMed
    Score: 0.004
  44. CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression. Oral Oncol. 2013 Apr; 49(4):306-13.
    View in: PubMed
    Score: 0.004
  45. High-resolution computed tomography analysis of the frontal sinus ostium: a pilot study. Am J Otolaryngol. 2013 Mar-Apr; 34(2):99-102.
    View in: PubMed
    Score: 0.004
  46. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis. Oral Oncol. 2012 Nov; 48(11):1076-84.
    View in: PubMed
    Score: 0.004
  47. Potential predisposition for nasal septal perforation with methotrexate use: report of 2 cases and literature review. Ear Nose Throat J. 2009 Aug; 88(8):E12-4.
    View in: PubMed
    Score: 0.003
  48. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Genes Chromosomes Cancer. 2003 Sep; 38(1):68-79.
    View in: PubMed
    Score: 0.002
  49. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res. 2003 Mar 15; 63(6):1351-8.
    View in: PubMed
    Score: 0.002
  50. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24). Genes Chromosomes Cancer. 2003 Feb; 36(2):205-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.